UBS Downgrades Auxilium Pharmaceuticals To Neutral

By: via Benzinga
Analysts at UBS downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral. Auxilium Pharmaceuticals shares have jumped ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.